Cargando…
Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1
SIMPLE SUMMARY: The unique properties of invariant natural killer T (iNKT) cells make them an attractive candidate for cancer-adoptive immunotherapy. However, despite their potential, clinical studies have not consistently shown successful outcomes. This lack of efficacy is likely attributed to the...
Autores principales: | Torre, Enza, Pinton, Giulia, Lombardi, Grazia, Fallarini, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340314/ https://www.ncbi.nlm.nih.gov/pubmed/37444608 http://dx.doi.org/10.3390/cancers15133498 |
Ejemplares similares
-
NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015) -
iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015) -
The Role of Autophagy in iNKT Cell Development
por: Yang, Guan, et al.
Publicado: (2018) -
Recent advances in iNKT cell development
por: Hogquist, Kristin, et al.
Publicado: (2020) -
Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023)